Download Citation
Article Source:
In a Subgroup of High-Risk Asians, Telmisartan Was Non-Inferior to Ramipril and Better Tolerated in the Prevention of Cardiovascular Events
Dans AL,
Teo K,
Gao P,
Chen JH,
Jae-Hyung K,
et al.
(2010)
In a Subgroup of High-Risk Asians, Telmisartan Was Non-Inferior to Ramipril and Better Tolerated in the Prevention of Cardiovascular Events.
PLOS ONE 5(12): e13694.
https://doi.org/10.1371/journal.pone.0013694